Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Markets & Finance

Goldman Upgrades Covance to 'Outperform'

Goldman Sachs upgraded Covance (CVD) to outperform from in-line.

Analyst Christopher McFadden says he increasingly believes Covance's diversified asset mix, strong positioning in the faster-growing preclinical and biotech-driven markets, and potential upside to 2004 earnings estimates are not currently reflected in the share price. He notes with a central lab, backlog growth concerns are largely reflected in Covance's valuation, and investors are presented with a compelling entry point based on a high level of earnings visibility through 2004.

McFadden notes at 6.6 times his 2004 EBITDA estimate, shares are at a discount to the group average of 7.1. He sees $1.21 2003 earnings per share, and $1.42 for 2004.

blog comments powered by Disqus